cagrilintide phase 3 (AM833) Novo Nordisk's CagriSema outperforms Ozempic

Reducing Inflammation Chronic inflammation in the gastrointestinal (GI) tract is a major contributor to conditions like IBS (irritable bowel syndrome), IBD (inflammatory bowel disease), or gut damage from ibuprofen and naproxen use

$74.99 Sale

These limitations dont invalidate the positive safety findings but do suggest that comprehensive medical supervision remains appropriate for anyone using AOD-9604, particularly for off-label applications or extended treatment periods

Understanding both the strength and limitations of this evidence base helps contextualize treatment decisions

Using a gentle moisturizer and sunscreen can help reduce discomfort